) [153]. This method is at the moment not scalable because it depends on pricey startup substrates that may be used to make psilocybin in more affordable chemical synthesis methodologies. A methodology for de novo creation of psilocybin and tryptamine derivatives in Saccharomyces cerevisiae,Scientific studies are acquiring that even modest doses of